Vivani Medical, Inc. (EYES)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Vivani Medical, Inc. (EYES)
Go deeper and ask any question about EYES
Company Performance
Current Price
as of Sep 13, 2024$1.29
P/E Ratio
N/A
Market Cap
$71.28M
Description
Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.
Metrics
Overview
- HQAlameda, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerEYES
- Price$1.29+4.03%
Trading Information
- Market Cap$71.28M
- Float54.64%
- Average Daily Volume (1m)96,456
- Average Daily Volume (3m)111,174
- EPS-$0.46
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$5.36M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$5.58M
- EV$64.44M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
Factset